Özet:

Aim. Gastric cancer is one of the leading causes of cancer-related deaths. The prognostic factors may affect decision of the treatment. In this retrospective study, we aimed to determine prognostic factors for non-metastatic gastric cancer in patients who were followed-up in our centre. Method. The data were obtained from patients’ file and the hospital records. The demographic parameters and pathological findings of the patients were recorded at the database. In addition to the laboratory tests of all patients, tumor,- and patient-related prognostic factors were also evaluated. Result. Data of 120 patients with gastric cancer at followed-up in our department between 2009 and 2011 were analyzed in this study. The mean age of the patients was 60±11, and 92 (77%) were male. Seventy-eight percent of gastric cancer (n=93) were localized in the distal. The most common occurred stage was stage 3 (71%). Of patients, lymphovascular invasion was 62% and 44% had poorly differentiated tumor. The most common performance status was ECOG “0” (64%). The median tumor size was 5 cm (1-15 cm). The number of median excised lymph node was 20 (2-54) and the median involved lymph node was 5 (0-44). Eighty percent of patients were lymph node positive. The median follow-up period was 22 months. The 3-year survival rates were decreasing according to stage. CEA elevation, stage, node involvement, performance status, extralymphatic extension, and anemia were prognostic factor for survival. CEA and the stage of disease were independently prognostic factors for survival. Conclusion. Stage and higher CEA independently affect survival in non-metastatic gastric cancer.

Anahtar Kelimeler: